Skip to main content
SpringerLink
Log in

Influence of the Nanocomposite MgAl-HTlc on Gastric Absorption of Drugs: In Vitro and Ex Vivo Studies

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Purpose

Furosemide (FURO) is a BCS class IV drug preferentially absorbed in the gastric environment. A previous study demonstrated that its intercalation into the lamellar inorganic matrix MgAl-HTlc, giving rise to MgAl-HTlc-FURO, improves its dissolution in acidic medium. As the gastric absorption of drugs can be hindered from the biological barriers mucus and gastric mucosa, the purpose of this work was to evaluate the effect of MgAl-HTlc on gastric pH, the possible modifications induced on mucus rheology and the influence on both artificial and biological membranes.

Methods

Firstly the effect of growing MgAl-HTlc concentrations on gastric pH was evaluated. Both drug flux across the mucus layer and permeability across an artificial and biological membrane (gastric mucosa) have been studied as well.

Results

The results highlighted that drug flux across gastric mucus is improved in presence of MgAl-HTlc-FURO and that MgAl-HTlc is able to modify mucus structure in a reversible manner. From permeability studies emerged that the use of a biological membrane is the most suitable for such studies and that MgAl-HTlc-FURO enhances FURO Papp.

Conclusions

Data obtained suggest that MgAl-HTlc is a suitable material able to improve the biopharmaceutical properties of class IV BCS drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

REFERENCES

  1. Dahan A, Miller JM, Amidon GL. Prediction of solubility and permeability class membership: provisional BCS classification of the world’s top oral drugs. AAPS J. 2009;11:740–6.

    Article  PubMed  CAS  Google Scholar 

  2. Varma MVS, Khandavilli S, Ashokraj Y, Jain A, Dhanikula A, Sood A, et al. Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. Curr Drug Metab. 2004;5:375–88.

    Article  PubMed  CAS  Google Scholar 

  3. Lipinski C. Poor aqueous solubility—an industry wide problem in drug delivery. Am Pharm Rev. 2002;5:82–5.

    Google Scholar 

  4. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413–20.

    Article  PubMed  CAS  Google Scholar 

  5. Hauss D. Oral lipid based formulations: enhancing the bioavailability of poorly water-soluble drugs. 1st ed. New York: Informa Healthcare, Marcel Dekker; 2007.

    Google Scholar 

  6. Whitehead K, Karr N, Mitragotri S. Discovery of synergistic permeation enhancers for oral drug delivery. J Control Release. 2008;128:128–33.

    Article  PubMed  CAS  Google Scholar 

  7. Ganem-Quintanar A, Kalia YN, Falson-Rieg F, Buri P. Mechanism of oral penetration enhancement. Int J Pharm. 1997;156:127–42.

    Article  CAS  Google Scholar 

  8. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The influence of excipients on the diffusion of ibuprofen and paracetamol in gastric mucus. Int J Pharm. 2005;290:145–54.

    Article  PubMed  CAS  Google Scholar 

  9. Lamont JT. Mucus: the front line of intestinal mucosal defense. Ann N Y Acad Sci. 1992;664:190–201.

    Article  PubMed  CAS  Google Scholar 

  10. Kaunitz JD. Barrier function of gastric mucus. Keio J Med. 1999;48:63–8.

    Article  PubMed  CAS  Google Scholar 

  11. Phillipson M, Johansson MEV, Henriksnäs J, Petersson J, Gendler SJ, Sandler S, et al. The gastric mucus layers: constituents and regulation of accumulation. Am J Physiol Gastrointest Liver Physiol. 2008;295:G806–12.

    Article  PubMed  CAS  Google Scholar 

  12. Khanvilkar K, Maureen O, Donovan D, Douglas Flanagan R. Drug transfer through mucus. Adv Drug Deliv Rev. 2001;48:173–93.

    Article  PubMed  CAS  Google Scholar 

  13. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61:158–71.

    Article  PubMed  CAS  Google Scholar 

  14. Salama NN, Eddington ND, Fasano A. Tight junction modulation and its relationship to the drug delivery. Adv Drug Deliv Rev. 2006;58:15–28.

    Article  PubMed  CAS  Google Scholar 

  15. Smith J, Wood E, Donish M. Effect of chitosan on epithelial cell tight junctions. Pharm Res. 2004;21:43–9.

    Article  PubMed  CAS  Google Scholar 

  16. Aungst BJ. Intestinal permeation enhancers. J Pharm Sci. 2000;89:429–42.

    Article  PubMed  CAS  Google Scholar 

  17. Cano-Cebrián MJ, Zornoza T, Granero L, Polache A. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery. Curr Drug Deliv. 2005;2:9–22.

    Article  PubMed  Google Scholar 

  18. Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev. 2001;5:S91–S101.

    Article  Google Scholar 

  19. Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 2004;278:119–31.

    Article  PubMed  CAS  Google Scholar 

  20. Constantinides PP, Wasan KM. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies. J Pharm Sci. 2007;96:235–48.

    Article  PubMed  CAS  Google Scholar 

  21. Goole J, Lindley DJ, Roth W, Carla SM, Amighi K, Kauffmann JM, et al. The effect of excipients on the transporter mediated absorption. Int J Pharm. 2010;393:17–31.

    Article  PubMed  CAS  Google Scholar 

  22. Del Hoyo C. Layered double hydroxides for novel biologic applications. Appl Clay Sci. 2007;36:103–21.

    Article  Google Scholar 

  23. Choy JH, Choi SJ, Oh JH, Park T. Clay minerals and layered double hydroxides for novel biological applications. Appl Clay Sci. 2007;36:122–32.

    Article  CAS  Google Scholar 

  24. Ambrogi V, Fardella G, Grandolini G, Perioli L. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents—I. Intercalation and in vitro release of ibuprofen. Int J Pharm. 2001;220:23–32.

    Article  PubMed  CAS  Google Scholar 

  25. Choy JH, Jung JS, Oh JM, Park M, Jeong J, Kang YK, et al. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials. 2004;25:3059–64.

    Article  PubMed  CAS  Google Scholar 

  26. Ambrogi V, Perioli L, Ciarnelli V, Nocchetti M, Rossi C. Effect of gliclazide immobilization into layered double hydroxide on drug release. Eur J Pharm Biopharm. 2009;73:285–91.

    Article  PubMed  CAS  Google Scholar 

  27. del Arco M, Fernández A, Martín C, Rives V. Intercalation of mefenamic and meclofenamic acid anions in hydrotalcite-like matrixes. Appl Clay Sci. 2007;36:133–40.

    Article  Google Scholar 

  28. Perioli L, Posati T, Nocchetti M, Bellezza F, Costantino U, Cipiciani A. Intercalation and release of antiinflammatory drug diclofenac into nanosized ZnAl hydrotalcite-like compound. Appl Clay Sci. 2011;53:374–8.

    Article  CAS  Google Scholar 

  29. Perioli L, Ambrogi V, di Nauta L, Nocchetti M, Rossi C. Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen. Appl Clay Sci. 2011;51:407–13.

    Article  CAS  Google Scholar 

  30. Perioli L, Ambrogi V, Nocchetti M, Sisani M, Pagano C. Preformulation studies on host-guest composites for oral administration of BCS class IV: HTlc and furosemide. Appl Clay Sci. 2011;53:696–703.

    Article  CAS  Google Scholar 

  31. Granero GE, Longhi ME, Mora MJ, Junginger HE, Midha KK, Shah VP, et al. Biowaiver monographs for immediate release solid oral dosage forms: furosemide. J Pharm Sci. 2010;99:2544–56.

    Article  PubMed  CAS  Google Scholar 

  32. Davis SS. Formulation strategies for absorption windows. Drug Discov Today. 2005;10:249–57.

    Article  PubMed  CAS  Google Scholar 

  33. Perioli L, Ambrogi V, Pagano C, Massetti E, Tiralti MC, Nocchetti M, et al. Nanostructured compounds to improve biopharmaceutical properties of drugs. 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Malta Valletta 8th–11th March 2010.

  34. Corti G, Maestrelli F, Cirri M, Zerrouk N, Mura P. Development and evaluation of an in vitro method for prediction of human drug adsorption II. Demonstration of the method suitability. Eur J Pharm Sci. 2006;27:354–62.

    Article  PubMed  CAS  Google Scholar 

  35. van der Bijl P, van Eyk AD. Permeability of human intestinal mucosa using a continuous flow-through perfusion system. Int J Pharm. 2002;235:71–8.

    Article  PubMed  Google Scholar 

  36. Bhat PG, Flanagan DR, Donovan MD. The limiting role of mucus in drug absorption: drug permeation through mucus solution. Int J Pharm. 1995;126:179–87.

    Article  CAS  Google Scholar 

  37. MacAdam A. The effect of gastrointestinal mucus on drug absorption. Adv Drug Deliv Rev. 1993;11:201–20.

    Article  CAS  Google Scholar 

  38. Bansil R, Turner BS. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci. 2006;11:164–70.

    Article  CAS  Google Scholar 

  39. Celli J, Gregor B, Turner B, Afdhal NH, Bansil R, Erramilli S. Viscoelastic properties and dynamics of porcine gastric mucin. Biomacromolecules. 2006;6:1329–33.

    Article  Google Scholar 

  40. Perioli L, D’Alba G, Pagano C. New oral solid dosage form for furosemide oral administration. Eur J Pharm Biopharm. 2012;80:621–9.

    Article  PubMed  CAS  Google Scholar 

  41. Khan AI, O’Hare D. Intercalation chemistry of layered double hydroxides: recent developments and applications. J Mater Chem. 2002;12:3191–8.

    Article  CAS  Google Scholar 

  42. Jobbágy M, Regazzoni AE. Dissolution of nano-size Mg-Al-Cl hydrotalcite in aqueous media. Appl Clay Sci. 2011;51:366–9.

    Article  Google Scholar 

  43. Maton PN, Burton ME. Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Drug. 1999;57:855–70.

    Article  CAS  Google Scholar 

  44. Schnaare RL, Block LH, Rohanin LC. Rheology. In: Troy DB, editor. Remington. The science and practice of pharmacy. 21st ed. Baltimore: Lippincott Williams & Wilkins; 2005. p. 350–1.

    Google Scholar 

  45. Grüber P, Bhaskar KR, Garik DR, Stanley HE, Lamont JT. Interaction of an aluminium-magnesium containing antacid and gastric mucus: possible contribution to the cytoprotective function of antacids. Aliment Pharmacol Ther. 1997;11:139–45.

    Article  Google Scholar 

  46. Madsen F, Eberth K, Smart J. A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. J Control Release. 1998;50:167–78.

    Article  PubMed  CAS  Google Scholar 

  47. Perioli L, Pagano C, Mazzitelli S, Rossi C, Nastruzzi C. Rheological and functional characterization of new antiinflammatory delivery system designed for buccal administration. Int J Pharm. 2008;356:19–28.

    Article  PubMed  CAS  Google Scholar 

  48. Taylor C, Allen A, Dettmar PW, Pearson JP. Two rheologically different gastric mucus secretions with different putative functions. Biochem Biophys Acta. 2004;1674:131–8.

    PubMed  CAS  Google Scholar 

  49. Raynal BDE, Hardingham TE, Sheehan JK, Thornton DJ. Calcium-dependent protein interactions in MUC5B provide reversible cross-links in salivary mucus. J Biol Chem. 2003;278:28703–10.

    Article  PubMed  CAS  Google Scholar 

  50. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man—fact or myth. Pharm Res. 1997;14:763–6.

    Article  PubMed  CAS  Google Scholar 

  51. Le Ferrec E, Chesne C, Artusson P, Brayden D, Fabre G, Gires P, et al. In vitro models of the intestinal barrier. ATLA. 2001;29:649–68.

    PubMed  Google Scholar 

  52. Neidfors P, Ekelund M, Jeppsson B, Weström BR. Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: species-and region-related differences. Scand J Gastroenterol. 2000;35:501–7.

    Article  Google Scholar 

Download references

ACKNOWLEDGMENTS AND DISCLOSURES

Authors are very grateful to Dr. Simonetta De Angelis and Dr. Elvio Capecci from ASL N. 1 (Città di Castello, Perugia, Italy), for providing pig samples. Special tanks are due to Mr. Marco Marani, from the Department of Chimica e Tecnologia del Farmaco, for his collaboration and technical assistance.

Author information

Authors and Affiliations

  1. Dipartimento di Chimica e Tecnologia del Farmaco, Università degli Studi di Perugia, Via del Liceo 1, Perugia, 06123, Italy

    Luana Perioli, Pamela Mutascio & Cinzia Pagano

Authors
  1. Luana Perioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pamela Mutascio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cinzia Pagano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luana Perioli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perioli, L., Mutascio, P. & Pagano, C. Influence of the Nanocomposite MgAl-HTlc on Gastric Absorption of Drugs: In Vitro and Ex Vivo Studies. Pharm Res 30, 156–166 (2013). https://doi.org/10.1007/s11095-012-0857-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-012-0857-7

KEY WORDS

Search

Navigation